Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?

Abstract : The disappointing recent failure of fluoroquinolone-containing regimens to shorten the duration of tuberculosis treatment in costly phase 3 trials has raised serious questions about the reliability of preclinical tuberculosis models, especially mice, and the current paradigm of regimen development. Therefore we re-examined data from murine models and early-stage clinical trials on which the pivotal trials were based, concluding that phase 3 trial results were in line with preceding studies. Finally, we offer suggestions for a more efficient and integrated preclinical and clinical regimen development program where quantitative pharmacokinetic and pharmacodynamic models more predictive of curative treatment durations are set forth.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03592729
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : mardi 1 mars 2022 - 15:13:21
Dernière modification le : mercredi 2 mars 2022 - 03:00:21

Lien texte intégral

Identifiants

Collections

Citation

Jean-Philippe Lanoix, Richard E. Chaisson, Eric L. Nuermberger. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?. CLINICAL INFECTIOUS DISEASES, 2016, 62 (4), pp.484-490. ⟨10.1093/cid/civ911⟩. ⟨hal-03592729⟩

Partager

Métriques

Consultations de la notice

4